Tamoxifen Clinical Trials

• Randomized, double-blind trial in postmenopausal women with primary breast cancer who have received adjuvant Tamoxifen for 2-3 years, comparing subsequent adjuvant treatment with an investigational drug with further Tamoxifen
  ClinicalTrials.gov Identifier: NCT00038467 - Active, not recruiting
  Breast Neoplasms
  
• Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00080743 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Examination of Tamoxifen in Acute Mania in Patients with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00026585 - Active, not recruiting
  Bipolar Disorder
  
• Exemestane Versus Tamoxifen in Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00036270 - Active, not recruiting
  Breast Neoplasms
  
• The Comparative Trial of UFT + TAM with CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
  ClinicalTrials.gov Identifier: NCT00152178 - Active, not recruiting
  Breast Cancer
  
• Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003016 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003906 - Active, not recruiting
  Breast Cancer
  
• A Phase II Trial of Tamoxifen and Bortezomib in Patients with Recurrent High-Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00108069 - Recruiting
  
  
• Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096369 - Active, not recruiting
  Breast Cancer; lobular breast carcinoma in situ
  
• Tamoxifen for the Prevention of Breast Cancer in High-Risk Women
  ClinicalTrials.gov Identifier: NCT00002644 - Active, not recruiting
  prevention of breast cancer; Breast Cancer
  
• Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Operable Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002580 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00053898 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00024336 - Active, not recruiting
  untreated childhood brain stem glioma
  
• Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005605 - Active, not recruiting
  Osteoporosis; stage I breast cancer; stage II breast cancer
  
• Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002581 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002777 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00032136 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002579 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Tamoxifen in Treating Patients With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002542 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00066690 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Tamoxifen in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003678 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Clodronate With or Without Chemotherapy and/or Tamoxifen in Treating Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009945 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
  ClinicalTrials.gov Identifier: NCT00126464 - Active, not recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
  ClinicalTrials.gov Identifier: NCT00068419 - Recruiting
  desmoid tumor
  
• Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
  ClinicalTrials.gov Identifier: NCT00077168 - Active, not recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• PROACT - Pre-Operative Arimidex Compared To Tamoxifen
  ClinicalTrials.gov Identifier: NCT00232661 - Active, not recruiting
  Breast Cancer
  
• Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
  ClinicalTrials.gov Identifier: NCT00295646 - Active, not recruiting
  Breast Cancer
  
• Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003418 - Active, not recruiting
  stage III breast cancer; stage I breast cancer; stage II breast cancer
  
• Lapatinib and Tamoxifen in Treating Patients with Locally Advanced Or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
  ClinicalTrials.gov Identifier: NCT00118157 - Recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002582 - Active, not recruiting
  stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
  
• Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005886 - Active, not recruiting
  stage I breast cancer; intraductal breast carcinoma; stage II breast cancer; breast cancer in situ
  
• Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00010140 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004205 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; breast cancer in situ; recurrent breast cancer; ductal breast carcinoma; ...
  
• Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
  ClinicalTrials.gov Identifier: NCT00072462 - Recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00041080 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Tamoxifen in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003424 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer; Quality of Life
  
• Randomized Study Comparing Tamoxifen Vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-Positive Patients
  ClinicalTrials.gov Identifier: NCT00309491 - Completed
  Early-Stage Breast Cancer
  
• Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00201851 - Active, not recruiting
  Breast Cancer
  
• Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002864 - Active, not recruiting
  stage I breast cancer; stage III breast cancer; stage II breast cancer; Quality of Life
  
• Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00206492 - Active, not recruiting
  Breast Cancer
  
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
  ClinicalTrials.gov Identifier: NCT00440349 - Active, not recruiting
  Retroperitoneal Fibrosis
  
• Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00290745 - Recruiting
  Breast Cancer
  
• Tamoxifen and Bortezomib in Treating Patients With Recurrent Gliomas
  ClinicalTrials.gov Identifier: NCT00112762 - Recruiting
  adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
  
• Liver Safety Under Upfront Arimidex vs Tamoxifen
  ClinicalTrials.gov Identifier: NCT00537771 - Recruiting
  Hormone Receptor+ Early Breast Cancer
  
• Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00538330 - Active, not recruiting
  Breast Cancer
  
• Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
  ClinicalTrials.gov Identifier: NCT00532454 - Recruiting
  Breast Cancer; Metastatic
  
• An open-label, multicenter, controlled study of Exemestane (Aromasin) with or without an investigational drug in postmenopausal women with advanced breast cancer (ABC) having progressed on Tamoxifen
  ClinicalTrials.gov Identifier: NCT00038103 - Active, not recruiting
  Breast Neoplasm
  
• Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00492687 - Recruiting
  Brain and Central Nervous System Tumors
  
• Luteal v. Follicular Phase Surgical Oophorectomy & Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor + Br. CA
  ClinicalTrials.gov Identifier: NCT00293540 - Recruiting
  Breast Cancer
  
• Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003050 - Active, not recruiting
  Breast Cancer
  
• Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
  ClinicalTrials.gov Identifier: NCT00489944 - Recruiting
  Intraocular Melanoma
  
• Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00492505 - Recruiting
  Melanoma (Skin)
  
• Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006030 - Active, not recruiting
  stage I breast cancer
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002784 - Active, not recruiting
  Breast Cancer
  
• Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
  ClinicalTrials.gov Identifier: NCT00165308 - Active, not recruiting
  Hodgkin's Disease; Breast Cancer
  
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00004125 - Active, not recruiting
  Breast Cancer
  
• Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle
  ClinicalTrials.gov Identifier: NCT00449514 - Recruiting
  Infertility
  
• Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002720 - Active, not recruiting
  stage I breast cancer
  
• Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Undergoing Treatment for Newly Diagnosed Breast Cancer
  ClinicalTrials.gov Identifier: NCT00569543 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00053339 - Not yet recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00365599 - Recruiting
  Breast Cancer
  
• High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003032 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00541086 - Recruiting
  Breast Cancer
  
• Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00424164 - Recruiting
  Breast Cancer
  
• Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002529 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003088 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002646 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002755 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
  ClinicalTrials.gov Identifier: NCT00541138 - Recruiting
  Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003972 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002680 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00003992 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002707 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy in Treating Women With Resected Breast Cancer
  ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003680 - Active, not recruiting
  inflammatory breast cancer; stage III breast cancer; Quality of Life
  
• Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002460 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002528 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00301457 - Recruiting
  Breast Cancer
  
• Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003035 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer
  
• Chemotherapy Plus Surgery in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003013 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003953 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
  
• Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002679 - Active, not recruiting
  Male Breast Cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003679 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer
  
• Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
  recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
  ClinicalTrials.gov Identifier: NCT00016432 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002608 - Completed
  Cancer
  
• Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003042 - Active, not recruiting
  stage IIIB breast cancer; inflammatory breast cancer
  
• Phase 3 study of LY353381 vs tamoxifen in women with locally advanced or metastatic breast cancer.
  ClinicalTrials.gov Identifier: NCT00034125 - Completed
  Breast Neoplasms
  
• Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009997 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
  
• Medroxyprogesterone in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002920 - Active, not recruiting
  Endometrial Cancer; stage I breast cancer; stage II breast cancer; intraductal breast carcinoma; lobular breast carcinoma in situ; ...
  
• CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
  ClinicalTrials.gov Identifier: NCT00305838 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Chemoprevention Therapy Plus Surgery in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003099 - Active, not recruiting
  stage I breast cancer; ductal breast carcinoma; invasive ductal breast carcinoma; prevention of breast cancer; stage II breast cancer
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00026286 - Active, not recruiting
  stage I breast cancer; ductal breast carcinoma; menopausal symptoms; Hot Flashes; stage II breast cancer; breast cancer in situ
  
• Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
  stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003199 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer